Tourette syndrome is a relatively common and complex neurobehavioral disorder characterized by motor and vocal (phonic) tics. Tics are abrupt, rapid, brief, repetitive behaviors that may resemble ...

By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...